Followers | 88 |
Posts | 8196 |
Boards Moderated | 0 |
Alias Born | 06/17/2013 |
Thursday, March 04, 2021 9:59:40 AM
and someone is gonna need a bigger basket to hold those IPs.
Bigger than an Easter basket :)
TSOI Patents and Applications filed by date
07-08-15 Augmentation of Oncology Immunotherapies by Pterostilbene Containing Compositions
09-02-15 Preventative Methods and Therapeutic or Pharmaceutical Compositions for the Treatment or Prevention of Pregnancy Complications
09-15-15 Diagnostic Methods For The Assessment Of Pregnancy Complications
09-25-15 A Medical Device For Reducing The Risk Of Preterm-Labor And Preterm-Birth
04-27-16 Augmentation Of Stem Cell Activity Using Pterostilbene And Compositions Containing Pterostilbene
03-29-17 Stimulation of Immunity to Tumor Stem Cell Specific Proteins by Peptide Immunization
03-29-17 Targeting the Tumor Microenvironment through Nutraceutical Based Immunoadjuvants
03-29-17 Activated Leukocyte Extract for Repair of Innate Immunity in Cancer Patients
03-29-17 Augmentation of Anti-Tumor Immunity by Mifepristone and Analogues Thereof
03-29-17 Methods of Re-Activating Dormant Memory Cells with Anticancer Activity
10-08-17 Synergistic Inhibition of Glioma Using Pterostilbene and Analogues Thereof
08-13-18 Enhancement of Ozone Therapy using Pterostilbene
09-17-18 Pterostilbene and Compositions Thereof for Prevention and Treatment of Chronic Traumatic Encephalopathy
09-25-18 Pterostilbene and Formulations Thereof for Treatment of Pathological Immune Activation
12-05-18 Treatment of Chronic Traumatic Encephalopathy via RNA Administration
01-09-19 Autologous Neurogenic Cells and Uses Thereof for Professional Athletes at Risk of Chronic Traumatic Encephalopathy
01-21-19 Prevention and Reversion of Chronic Traumatic Encephalopathy through Administration of “Educated” Monocytes and Progenitors Thereof
09-09-19 Pterostilbene and Formulations Thereof for Protection of Hematopoiesis from Chemotherapy and Radiation
11-04-19 Cellular, Organ, and Whole-Body Rejuvenation Utilizing Cord Blood Plasma and Pterostilbene
05-04-2020 Nutraceuticals for the Prevention, Inhibition and Treatment of SARS-Cov-2 and Associated COVID-19
05-11-2020 Treatment of COVID-19 Lung Injury Using Umbilical Cord Plasma Based Compositions
06-11-2020 Nutraceuticals for Reducing Myeloid Suppressor Cells
06-15-2020 Nutraceuticals for Suppressing Indolamine 2,3 Deoxygenase
06-22-2020 Treatment of SARS-CoV-2 with Dendritic Cells for Innate and/or Adaptive Immunity
06-30-2020 Augmentation of Natural Killer Cell Activity and Induction of Cytotoxic Immunity Using Leukocyte Lysate Activated Allogeneic Dendritic Cells: StemVacs™
07-13-2020 Prevention of Pathological Coagulation in COVID-19 and other Inflammatory Conditions
07-22-2020 Additive and/or Synergistic Combinations of Metformin with Nutraceuticals for the Prevention, Inhibition and Treatment of SARS-Cov-2 and Associated COVID-19
07-28-2020 Neuroprotection and Neuroregeneration by Pterostilbene and Compositions Thereof
08-05-2020 Prevention of Neuroinflammation associated Memory Loss Using Nutraceutical Compositions
08-21-2020 Methods of Determining Risk of Suicide and/or Suicidal Ideation by Immunological Assessment
08-28-2020 Upregulation of Therapeutic T Regulatory Cells and Suppression of Suicidal Ideations in Response to Inflammation by Administration of Nutraceutical Compositions Alone or Combined with Minocycline
09-14-2020 Immunotherapy of Schizophrenia and Schizophrenia Associated Suicidal Ideation/Suicide
09-24-2020 Personalized Immunotherapies for Reduction of Brain Inflammation and Suicide Prevention
10-18-2020 Nutraceutical Reduction Prevention and/or Reversion of Multiple Sclerosis
10-27-2020 Protection/Regeneration of Neurological Function by Endothelial Protection/Rejuvenation using Stem Cells for Treatment of Conditions such as Chronic Traumatic Encephalopathy and Schizophrenia
11-24-2020 Stimulation of NK Cell Activity by QuadraMune Alone and together with Metformin
12-08-2020 Treatment of Major Depressive Disorder and Suicidal Ideations Through Stimulation of Hippocampal Neurogenesis Utilizing Plant-Based Approaches
12-21-2020 Immunotherapy for Opioid Addiction
01-26-2021 Stimulation of Dendritic Cell Activity by Homotaurine and Analogues Thereof
02-08-2021 Stimulation of Natural Kill Cell Memory by Administration of Dendritic Cells
02-22-2021 Ex Vivo Generation of Immunocytes Recognizing Brother of the Regulator of Imprinted Sites (BORIS) Expressing Cancer Stem Cells
Recent TSOI News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 10:03:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 07:15:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 07:12:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 10:25:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 11:16:15 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/08/2024 05:15:25 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/06/2024 11:34:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 08:42:55 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/17/2024 11:15:01 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/04/2024 09:03:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 07:44:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:39:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 11:17:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 11:13:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 06:50:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 05:44:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:24:52 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 11:10:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:29:10 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM